Gene · 10189
Papers1,565
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 1,565
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Construction of disulfidptosis-related lncRNA signature for predicting the prognosis and immune escape in colon adenocarcinoma. | BMC Gastroenterol | 2023 | 37946148 | PubTator, text mining | PubMed |
| MePMe-seq: antibody-free simultaneous m6A and m5C mapping in mRNA by metabolic propargyl labeling and sequencing. | Nat Commun | 2023 | 37935679 | PubTator, text mining | PubMed |
| Identification of M5c regulator-medicated methylation modification patterns for prognosis and immune microenvironment in glioma. | Aging (Albany NY) | 2023 | 37934565 | PubTator, text mining | PubMed |
| Pancancer analysis of the correlations of HS6ST2 with prognosis, tumor immunity, and drug resistance. | Sci Rep | 2023 | 37932473 | PubTator, text mining | PubMed |
| Regulatory role of RNA modifications in the treatment of pancreatic ductal adenocarcinoma (PDAC). | Heliyon | 2023 | 37928039 | PubTator, text mining | PubMed |
| Identification and validation of novel prognostic signatures based on m5C methylation patterns and tumor EMT profiles in head and neck squamous cell carcinoma. | Sci Rep | 2023 | 37907576 | PubTator, text mining | PubMed |
| Dual agonistic and antagonistic roles of ZC3H18 provide for co-activation of distinct nuclear RNA decay pathways. | Cell Rep | 2023 | 37889751 | PubTator, text mining | PubMed |
| Thirty Years with ERH: An mRNA Splicing and Mitosis Factor Only or Rather a Novel Genome Integrity Protector? | Cells | 2023 | 37887293 | PubTator, text mining | PubMed |
| Shining a spotlight on m6A and the vital role of RNA modification in endometrial cancer: a review. | Front Genet | 2023 | 37886684 | PubTator, text mining | PubMed |
| RNA modification in cardiovascular disease: implications for therapeutic interventions. | Signal Transduct Target Ther | 2023 | 37884527 | PubTator, text mining | PubMed |
| CDK13 promotes lipid deposition and prostate cancer progression by stimulating NSUN5-mediated m5C modification of ACC1 mRNA. | Cell Death Differ | 2023 | 37845385 | PubTator, text mining | PubMed |
| The Nuclear Cap-Binding Complex, a multitasking binding partner of RNA polymerase II transcripts. | J Biochem | 2023 | 37830942 | PubTator, text mining | PubMed |
| Genomic communication via circulating extracellular vesicles and long-term health consequences of COVID-19. | J Transl Med | 2023 | 37817137 | PubTator, text mining | PubMed |
| Identification of m5C-related molecular subtypes and prediction models in the prognosis and tumor microenvironment infiltration of soft tissue sarcoma. | Heliyon | 2023 | 37809908 | PubTator, text mining | PubMed |
| The Cajal body protein p80-coilin forms a complex with the adenovirus L4-22K protein and facilitates the nuclear export of adenovirus mRNA. | mBio | 2023 | 37795984 | PubTator, text mining | PubMed |
| Identification of novel lactate metabolism-related lncRNAs with prognostic value for bladder cancer. | Front Pharmacol | 2023 | 37781694 | PubTator, text mining | PubMed |
| Development and validation of prognostic index based on purine metabolism genes in patients with bladder cancer. | Front Med (Lausanne) | 2023 | 37780567 | PubTator, text mining | PubMed |
| Helicases in R-loop Formation and Resolution. | J Biol Chem | 2023 | 37778731 | PubTator, text mining | PubMed |
| Identification of m6A suppressor EIF4A3 as a novel cancer prognostic and immunotherapy biomarker through bladder cancer clinical data validation and pan-cancer analysis. | Sci Rep | 2023 | 37777564 | PubTator, text mining | PubMed |
| A CRISPR Screen of HIV Dependency Factors Reveals That CCNT1 Is Non-Essential in T Cells but Required for HIV-1 Reactivation from Latency. | Viruses | 2023 | 37766271 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10189/papers?page=10